Antitumor activity of nivolumab in recurrent and metastatic nasopharyngeal carcinoma: An international, multicenter study of the mayo clinic phase 2 consortium (NCI-9742)

Brigette B.Y. Ma, Wan Teck Lim, Boon Cher Goh, Edwin P. Hui, Kwok Wai Lo, Adam Pettinger, Nathan R. Foster, Jonathan W. Riess, Mark Agulnik, Alex Y.C. Chang, Akhil Chopra, Julie A. Kish, Christine H. Chung, Douglas R. Adkins, Kevin J. Cullen, Barbara J. Gitlitz, Dean W. Lim, Ka Fai To, K. C.Allen Chan, Y. M.Dennis LoAnn D. King, Charles Erlichman, Jun Yin, Brian A. Costello, Anthony T.C. Chan

Research output: Contribution to journalArticlepeer-review

223 Scopus citations

Fingerprint

Dive into the research topics of 'Antitumor activity of nivolumab in recurrent and metastatic nasopharyngeal carcinoma: An international, multicenter study of the mayo clinic phase 2 consortium (NCI-9742)'. Together they form a unique fingerprint.

Medicine & Life Sciences